Charles River Laboratories International, Inc. (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   May 6, 2010

Charles River Laboratories International, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 001-15943 06-1397316
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
251 Ballardvale St., Wilmington, Massachusetts   01887
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   978-658-6000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 5.07. Submission of Matters to a Vote of Security Holders

Charles River Laboratories International, Inc. (the “Company”) held its Annual Meeting of Shareholders on May 6, 2010, For more information on the following proposals, see the Company’s proxy statement dated March 30, 2010. At the Annual Meeting the proposals were adopted by the votes specified below:

  (a)   The following directors were elected to serve until the Company’s 2011 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below:
                         
    Number of   Number of    
    Shares Voted For   Shares Withheld   Broker Non-Votes
James C. Foster
     53,187,221       2,418,975       2,146,907  
Nancy T. Chang
     43,962,929       11,643,267       2,146,907  
Stephen D. Chubb
     52,346,043       3,260,153       2,146,907  
Deborah T. Kochevar.
     46,828,226       8,777,970       2,146,907  
George E. Massaro
     53,221,956       2,384,240       2,146,907  
George M. Milne, Jr.
     43,848,036       11,758,160       2,146,907  
C. Richard Reese
     54,356,225       1,249,971       2,146,907  
Douglas E. Rogers
     44,229,172       11,377,024       2,146,907  
Samuel O. Thier
     54,310,604       1,295,592       2,146,907  
William H. Waltrip
     42,972,092       12,634,104       2,146,907  

  (b)   The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors for fiscal 2010. A total of 55,846,976 shares voted in favor of the ratification, 1,696,529 shares voted against the ratification, and 209,598 shares abstained from voting. There were no broker non-votes for this proposal.

Computershare Trust Company, N.A., our transfer agent, acted as independent proxy tabulator and Inspector of Election at the Annual Meeting of Shareholders.

Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Charles River Laboratories International, Inc.
          
May 11, 2010   By:   Matthew L. Daniel
       
        Name: Matthew L. Daniel
        Title: Deputy General Counsel and Assistant Secretary